Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Fibroblast activation protein inhibitor
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Most Relevant Literature
- Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligop…
- Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cell…
- Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibrobla…
- Fibroblast activation protein: A potential therapeutic target in cancer.
- Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fi…
Most Relevant Clinical Trials
- Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System
- Fibroblast Activating Protein Inhibitor PET Imaging in Lupus Nephritis
- The Function of PET Molecular Imaging Targeting Fibroblast Activation Protein in the Hepatobiliary M…
- Clinical Application of Fibroblast Activation Protein PET/MRI in Liver Fibrosis
- Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant…
